Back to Knowledge Center

Active Trials

A Pilot Study to Determine the Safety and Efficacy of Repetitive Transcranial Magnetic Stimulation by Rotating Fields for the Treatment of patients with Depression

Geha Mental Health Center, Israel Clinical depression is one of the most common mental disorders. BrainsWay has successfully

Treatment of comorbid depression and cognitive impairment in older adults with Alzheimer’s disease using deep transcranial magnetic stimulation

Baycrest Health Sciences, Toronto, Canada Alzheimer’s disease is an increasing issue in the aging population with 66 million

A Pilot Study to Determine the Safety and Efficacy of dual channel deep transcranial magnetic stimulation for the treatment of acute ischemic stroke patients

Ben Gurion University of the Negev, Israel Stroke is among the principal causes of death worldwide and even in the best-case

Comparison of the analgesic effects of two methods of repetitive magnetic transcranial stimulation: A randomized double blind sham controlled study in patients with central neuropathic pain

Ambroise Paré hospital France, Henri Mondor hospital France, Oslo University Norwey Neuropathy is common in the diabetic population,

New Hope for Your Major Depressive Disorder (MDD)

Take Part in an FDA Approved Study for MDD with the latest Deep TMS Technology by BrainsWay About BrainsWay treatment (Deep TMS) BrainsWay*